Sponsored by:
Vetter Pharma
Vetter is an international specialist in the production of aseptically prefilled syringe systems, cartridges and vials.
Vetter is an international specialist in the production of aseptically prefilled syringe systems, cartridges and vials. Our focus is on providing highly skilled support and state-of-the-art manufacturing resources - we are a Contract Development and Manufacturing Organization (CDMO) supporting our customers from the initial phases of clinical development and regulatory approval process through successful product launch, commercial manufacturing, and life cycle management.
Facts about Vetter
80%
Of our active projects are biologics
We offer extensive expertise with complex, sensitive compounds.
10-15
Inspections each year
By different international regulatory authorities.
15+
Cleanrooms in the US and Germany
With capabilities to manufacture small and large batch units.
Our Services
Clinical Manufacturing
With Vetter, you have a partner you can trust to support you throughout drug product development, clinical manufacturing and regulatory approval. We are ready to provide clinical fill and finish for different batch sizes and with a variety of injection systems, from vials, syringes and cartridges. Take advantage of our ongoing investment in technology and quality and our comprehensive services.
Commercial Manufacturing
Commercial manufacturing of pharmaceutical and biotech drugs is a complex business today, requiring close integration of sophisticated resources and technologies to deliver top quality and solve supply chain challenges. Vetter’s decades of experience as a contract manufacturer providing fill and finish for injectable drugs (prefilled syringes, vials, and cartridges) helps deliver results for pharmaceutical and biotechnology companies both large and small.
Benefits of Vetter
With Vetter, you get the advantages of working with a partner who knows how to take your compound from preclinical to clinical to commercial manufacturing:
- Expertise in the development of a broad range of drugs, including sensitive biologics
- Technology, processes, and resources to achieve developmental milestones
- Clinical manufacturing facilities in the US and Germany
